Article info
PDFStomach
Original research
Epidemiology and outcomes of gastroparesis, as documented in general practice records, in the United Kingdom
- Correspondence to Dr Yizhou Ye, Global Evidence and Outcomes, Takeda Pharmaceutical Co Ltd, Cambridge 02139, Massachusetts, USA; james.ye{at}takeda.com
Citation
Epidemiology and outcomes of gastroparesis, as documented in general practice records, in the United Kingdom
Publication history
- Received March 31, 2020
- Revised May 6, 2020
- Accepted May 7, 2020
- First published June 3, 2020.
Online issue publication
March 05, 2021
Article Versions
- Previous version (3 June 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.